Search results for: Koonal Shah
Filter search results
The Broader Value of Existing Vaccines in the Fight Against COVID-19: Beware of Tunnel Vision
8 October 2020
…20 August 2020. Hernandez-Villafuerte, K., Shah, K., Herdman, M and Lorgelly, P. (2018). Meningococcal Vaccines: An International Comparison of Decision Making Processes, Frameworks and Methodologies. Are Values Missing? OHE Consulting…
Should We ‘Drop Dead’ from Health State Valuation?
10 December 2020
…of Health Economics. Available at: https://www.ohe.org/publications/drop-dead-anchoring-%E2%80%98dead%E2%80%99-theoretical-requirement-health-state-valuation Shah, K.K., Ramos-Goñi, J.M., Kreimeier, S. and Devlin, N.J., 2020. An exploration of methods for obtaining = dead anchors for latent scale EQ-5D-Y values. The European…
To Hell with the 3L! NICE’s Missed Opportunity to Upgrade Health Outcome Measurement
2 March 2022
…Shah, K.K., Feng, Y., Mulhern, B. and van Hout, B., 2018. Valuing health-related quality of life: An EQ-5D-5L value set for England. Health Economics, 27(1), pp.7–22. DOI Herdman, M., Gudex,…
NICE’s severity modifier: a step in the right direction, but still a long way to go
23 March 2022
…Furthermore, UK-based societal preference studies typically did not find evidence in support of an end-of-life premium (Shah et al., 2018). NICE’s new health technology evaluation manual replaces the EOL criteria…
Exploring the Interdependencies of Research Funders in the UK
1 July 2014
…and can be downloaded from: http://link.springer.com/article/10.1186%2Fs12961-015-0027-6 Please cite as: Shah, K., Sussex, J. and Hernandez-Villafuerte, K., 2015. Government and charity funding of cancer research: public preferences and choices. Health Research…
The UK’s Publicly Funded Vaccines Market
23 November 2010
…appear willing to continue with the current, centralised system, albeit with some tinkering around the edges. Download Sussex, J. and Shah, K.K. (2010) The publicly funded vaccines market in the…
Australia’s Publicly Funded Vaccines Market
1 December 2010
…approach could carry some risks for suppliers, DoHA’s well-established practice of splitting the market among vaccine manufacturers mitigates this and is expected to continue. Download Sussex, J., Shah, K. and Butler,…
QALYs v. Other Criteria in NHS Decisions
17 May 2011
…relative importance of those goals, could improve welfare, they conclude. Download Shah, K.K., Praet, C., Devlin, N.J., Sussex, J.M., Appleby, J. and Parkin, D. (2011) Is the aim of the…
New OHE Study Compares Decisions by Five HTA Agencies on Oncology Meds
31 January 2013
…HTA agencies sometimes reach different conclusions about the same medicines. The authors discuss possible reasons for these differences and offer recommendations for improving HTA processes. Shah, K.K., Mestre-Ferrandiz, J., Towse,…